UM

Ujwala Mukund Patil

Active Director Designated Partner DIN 11734177
DIN 11734177 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ujwala Mukund Patil

Data last updated:

Ujwala Mukund Patil is a Designated Partner at Novel Institute Of Pharma Skills Development & Placement Llp (since 2026).

DIN 11734177
Primary Designation Designated Partner
First Appointment 21 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 May 20262026Active

Board colleagues of Ujwala Mukund Patil

Directorship timeline

Open interactive timeline →
Novel Institute Of Pharma Skills Development & Placement Llp
Premium access

Shareholding and investment profile for Ujwala Mukund Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ujwala Mukund Patil

Ujwala Mukund Patil currently holds 1 directorship: Novel Institute Of Pharma Skills Development & Placement Llp (Designated Partner, since 21 May 2026).

Ujwala Mukund Patil was first appointed on 21 May 2026 as Designated Partner at Novel Institute Of Pharma Skills Development & Placement Llp.

The current boards of Ujwala Mukund Patil's companies include Vitthal Gangaramji Shinde (Novel Institute Of Pharma Skills Development & Placement Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available